SDC2 and neoplasm: To demonstrate this, Whiteford et al. [143] generated an expression system in HEK293T cells in which the syndecan-2 ectodomain (S2ED) was constitutively released from the cells, and the anti-angiogenic properties of the shed syndecan-2 in a xenograft tumor model were investigated.